Altered localization and activity of canalicular Mrp2 in estradiol-17beta-D-glucuronide-induced cholestasis.
Estradiol-17beta-D-glucuronide (E(2)17G), an endogenous metabolite of estradiol, induces a potent dose-dependent and reversible inhibition of bile flow in the rat. We analyzed the effect of a single dose of E(2)17G (15 micromol/kg, intravenously) to female rats on bile flow and the endocytic retrieval and function of the canalicular multidrug resistance-associated protein 2 (Mrp2) and the effect of pretreatment with dibutyryl-cyclic AMP (DBcAMP; 20 micromol/kg) on these measures. Bile flow was maximally inhibited by 85% within 10 minutes of E(2)17G and returned to 50% and 100% of control levels within 75 and 120 minutes, respectively. Western analysis of total homogenates and mixed plasma and intracellular membranes suggested partial internalization of Mrp2 during the acute phase of cholestasis at 20 minutes and during the period of recovery from cholestasis at 75 minutes, which returned to control levels by 180 minutes after E(2)17G. Confocal analysis confirmed Western studies and demonstrated endocytic retrieval of Mrp2 from the canalicular membrane into pericanalicular and intracellular domains. The biliary concentration and excretion of the model Mrp2 substrate, dinitrophenyl-S-glutathione (DNP-SG), was impaired in parallel with the extent of Mrp2 retrieval. Pretreatment with DBcAMP partially protected against maximal E(2)17G cholestasis and the endocytic retrieval and decreased function of Mrp2 at 20 minutes and significantly accelerated the exocytic insertion of Mrp2 into the canalicular membrane and the recovery of bile flow and biliary excretion of DNP-SG. In conclusion, these data indicate that E(2)17G induces endocytic internalization of Mrp2, which occurs in parallel with decreased bile flow and Mrp2 transport activity.
Mottino
Aldo D
AD
Graduate Center for Toxicology, University of Kentucky, Lexington, KY 40536-0305, USA.
Cao
Jingsong
J
Veggi
Luis M
LM
Crocenzi
Fernando
F
Roma
Marcelo G
MG
Vore
Mary
M
D000818:Animals; D001646:Bile / Q000378:metabolism; D001648:Bile Canaliculi / Q000737:chemistry / Q000378:metabolism*; D001692:Biological Transport / Q000502:physiology; D003994:Bucladesine / Q000494:pharmacology; D002779:Cholestasis / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism*; D004958:Estradiol; D005260:Female; D005455:Fluorescent Antibody Technique; D020719:Glucuronides; D005978:Glutathione / Q000031:analogs & derivatives* / Q000378:metabolism; D008565:Membrane Proteins / Q000032:analysis / Q000378:metabolism; D026901:Membrane Transport Proteins; D000089762:Multidrug Resistance-Associated Protein 2; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000032:analysis / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley
D003994:Bucladesine; D004958:Estradiol; D020719:Glucuronides; D005978:Glutathione; D008565:Membrane Proteins; D026901:Membrane Transport Proteins; D000089762:Multidrug Resistance-Associated Protein 2; D027425:ATP-Binding Cassette, Sub-Family C Proteins; C030190:S-(2,4-dinitrophenyl)glutathione; C421109:multidrug resistance-associated protein 1